Xin Su | Infectious Diseases | Best Researcher Award

Published on by Infectious

Dr. Xin Su | Infectious Diseases | Best Researcher Award

Attending Physician | Nanjing University | China

Professor Xin Su, M.D., Ph.D., is a distinguished clinical scientist and Chief Physician renowned for his pioneering contributions to respiratory and critical care medicine, with particular expertise in the study and management of severe pulmonary infections. Over a distinguished career spanning nearly three decades, he has demonstrated an exceptional ability to bridge clinical excellence with translational research innovation. His work focuses on the pathogenesis, diagnosis, and treatment of invasive pulmonary aspergillosis (IPA) in non-neutropenic patients, a challenging and underexplored domain of pulmonary medicine. As a leading investigator, Professor Su has spearheaded multicenter studies that have transformed the understanding of pulmonary fungal infections, combining rigorous clinical observation with the use of novel diagnostic technologies, including machine learning and metagenomic sequencing. His publications in high-impact journals such as The Lancet Infectious Diseases, Microbiology Spectrum, Frontiers in Cellular and Infection Microbiology, and Clinical Microbiology and Infection reflect a deep commitment to advancing evidence-based practices and diagnostic accuracy in the field. Through his groundbreaking studies, Professor Su has introduced innovative diagnostic models that integrate big data analytics with clinical biomarkers, offering more precise and timely identification of IPA and related fungal diseases. Beyond diagnostics, his investigations into host immune responses, interferon signaling, and biomarker development have opened new avenues for prognostic assessment and personalized treatment strategies. His leadership roles as a Chief Physician, Professor, and Doctoral Supervisor at Nanjing University-affiliated hospitals underscore his dual impact as both a clinician and academic mentor. Colleagues and collaborators recognize his unique ability to unite global expertise, as evidenced by his participation in international research consortia addressing fungal infections and severe pneumonia outcomes. His scholarly rigor, coupled with his mentorship of young clinicians and researchers, has significantly enriched the field of respiratory and infectious disease research. While Professor Su’s scientific achievements are substantial, he continues to identify strategic growth areas that align with the evolving challenges of respiratory medicine. Expanding the clinical utility of machine learning-based diagnostic platforms, validating novel biomarkers in diverse patient populations, and enhancing global collaborative networks remain key objectives. Moreover, strengthening translational pathways that connect molecular diagnostics to frontline patient care is an ongoing priority, ensuring that innovations in the laboratory translate into improved clinical outcomes. Looking ahead, Professor Su’s future research aims to deepen the mechanistic understanding of host-pathogen interactions in fungal and viral co-infections, refine AI-driven diagnostic algorithms for pulmonary infections, and integrate multi-omics data into clinical decision-making frameworks. His vision is to establish an internationally recognized precision-medicine model for diagnosing and managing severe respiratory infections, ultimately contributing to reduced mortality, optimized therapeutic strategies, and global health resilience in the era of emerging respiratory pathogens. He has 2677 citations from 128 documents with an h-index of 28.

Profiles: Scopus | ORCID

Publications

1. Diagnostic and prognostic roles of interferon-λ1 and interferon-λ3 in bronchoalveolar lavage fluid and plasma in non-neutropenic patients with invasive pulmonary aspergillosis. (2025). Microbiology Spectrum.

2. Rapid and accurate diagnosis of severe pneumonia: Similarities and differences between severe community-acquired pneumonia and hospital-acquired pneumonia/ventilator-associated pneumonia. (2025). Chinese Journal of Tuberculosis and Respiratory Diseases.

3. Development and validation of a machine learning-based diagnostic model for identifying nonneutropenic invasive pulmonary aspergillosis in suspected patients: A multicenter cohort study. (2025). Microbiology Spectrum.

4. Expert consensus on cancer treatment-related lung injury. (2025). Journal of Thoracic Disease.

5. Pentraxin-3 as a novel prognostic biomarker in non-neutropenic invasive pulmonary aspergillosis patients. (2025). Microbiology Spectrum.

Abdul-rahman Mumbu | Epidemiology | Best Researcher Award

Published on by Infectious

Mr. Abdul-rahman Mumbu | Epidemiology | Best Researcher Award

Lecturer | Muslim University of Morogoro | Tanzania

Dr. Abdul-Rahman Japhary Mumbu is a dedicated Lecturer in Mathematics at the Muslim University of Morogoro, Tanzania, recognized for his expertise in applied mathematics, mathematical modeling, and epidemiological systems. He holds a Bachelor of Islamic Education (Mathematics/Islamic Studies) from the Muslim University of Morogoro, a Master of Science in Mathematics from the University of Dodoma, and is currently pursuing a Ph.D. in Mathematics at the University of Dar es Salaam. His professional journey reflects progressive academic leadership, having served as an Assistant Lecturer, Examinations Officer, and active participant in numerous international workshops and conferences on infectious disease modeling, partial differential equations, and data-driven research integration. Dr. Mumbu’s research primarily focuses on mathematical modeling of infectious diseases, with notable contributions to tuberculosis, pneumonia, and rabies dynamics, employing deterministic and fractional-order approaches integrated with sensitivity and optimal control analyses. His scholarly works, published in reputable journals such as Nonlinear Science, Scientific African, and Research in Mathematics, highlight his commitment to advancing public health modeling and data-driven decision-making. With 40 citations, 4 publications, and an h-index of 2, Dr. Mumbu continues to make impactful contributions to mathematical epidemiology and interdisciplinary research collaboration.

Profiles: Scopus | Google Scholar

Featured Publications

1. Mumbu, A. J., & Hugo, A. K. (2020). Mathematical modelling on COVID-19 transmission impacts with preventive measures: A case study of Tanzania. Journal of Biological Dynamics, 14(1), 748–766.

2. Mumbu, A. (2024). Modeling dynamics and stability analysis of pneumonia disease infection with parameters uncertainties control. Mathematics Open, 3(2430001), 1–35.

3. Abdulrahman, M., James, D., Dickson, B., & Jufren, N. (2025). Mathematical modeling of culling and vaccination for dog rabies disease transmission with optimal control and sensitivity analysis approach. Clinical and Molecular Epidemiology, 2(2), 1–11.

4. Mumbu, A., Mlay, G., Mayige, M., & Shaban, N. (2025). Modeling the transmission dynamics of two-strain TB with drug-sensitive and drug-resistant in Tanzania: A fractional order approach. Scientific African, e02731.

5. Mumbu, A. R., Mlay, G., Alendal, G., Mayige, M., Senkoro, M., & Shaban, N. (2025). Fractional order derivative modelling dynamics of tuberculosis with treatment and nutrition in Tanzania. Research in Mathematics, 12(1), 2517440.

Wafa Tombari | Vaccines | Best Researcher Award

Published on by Infectious

Assist. Prof. Dr. Wafa Tombari | Vaccines | Best Researcher Award

Assistant Professor | University Hospital of Sahloul | Tunisia

Dr. Wafa Tombari, Ph.D., is an accomplished Assistant Professor and Research Scientist at the University Hospital of Sahloul, Sousse, specializing in infectious diseases with a focus on virology, vaccine development, and antimicrobial resistance. She holds a Doctoral Diploma in Biology from the Faculty of Sciences in Tunisia, a Master of Science in Microbiology, and a Certificate of Complementary Studies in Statistics and Epidemiological Methods from the Faculty of Medicine in Tunisia. With a distinguished academic and research career, Dr. Tombari has served as an Assistant Professor at both the High Institute of Medical Technologies and the University Hospital of Sahloul, where she has successfully led and collaborated on numerous national and international research projects. Her research integrates molecular biology, bioinformatics, and immunoinformatics to develop computational approaches for vaccine design, antiviral therapeutics, and the study of bacterial resistance mechanisms. She has authored several peer-reviewed publications in reputable international journals, including studies on mRNA-based vaccines for rabies virus and molecular characterization of antimicrobial resistance in Staphylococcus species, highlighting her contributions to advancing biomedical innovation. Beyond her research, Dr. Tombari plays an active role in student mentorship, curriculum development, and scientific outreach, fostering collaboration and innovation within the academic community. Her expertise extends to reverse vaccinology, molecular cloning, and phylogenetic analysis, reflecting her multidisciplinary approach to infectious disease research. Dr. Tombari’s scholarly achievements and professional dedication exemplify her commitment to advancing global health through science and education. She has achieved 119 citations, published 10 scientific documents, and holds an h-index of 5, reflecting her academic influence and research excellence.

Profiles: Scopus | Google Scholar

Featured Publications

1. Tombari, W., Nsiri, J., Larbi, I., Guerin, J. L., & Ghram, A. (2011). Genetic evolution of low pathogenicity H9N2 avian influenza viruses in Tunisia: . Acquisition of new mutations. Virology Journal, 8(1), 467.

2. Tombari, W., Paul, M., Bettaieb, J., Larbi, I., Nsiri, J., Elbehi, I., Gribaa, L., & Ghram, A. (2013). Risk factors and characteristics of low pathogenic avian influenza virus isolated from commercial poultry in Tunisia. PLoS ONE, 8(1), e53524.

3. Boudaoud, A., Mamache, B., Tombari, W., & Ghram, A. (2016). Virus mutations and their impact on vaccination against infectious bursal disease (Gumboro disease). Revue Scientifique et Technique, 35(3), 875–897.

4. Kallel Sellami, M., Zitouni, M., Tombari, W., Ben Ayed, M., Abida, O., Laadhar, L., et al. (2007). Anti-desmoglein-1 antibodies are prevalent in Tunisian patients with hydatidosis and leishmaniasis. British Journal of Dermatology, 156(3), 591–593.

Chalachew Yenew | Neglected Tropical Diseases | Best Paper Award

Published on by Infectious

Mr. Chalachew Yenew | Neglected Tropical Diseases | Best Paper Award

Lecturer | Debre Tabor University | Ethiopia 

Dr. Chalachew Yenew Dinku is an accomplished Lecturer and Researcher at Debre Tabor University, Ethiopia, specializing in Environmental and Public Health, with a research focus on environmental and occupational exposure, antimicrobial resistance (AMR), infection prevention and control, One Health, and public health emergency management. He holds a Master of Science in Environmental Health Sciences from Jimma University, where his thesis on AMR contamination pathways received an international research grant and resulted in multiple peer-reviewed publications. He earned his Bachelor of Science in Environmental and Occupational Health and Safety from the University of Gondar, where his undergraduate research on hospital indoor bacterial contamination gained national recognition. With over nine years of professional experience, Dr. Yenew has held key academic and public health roles, including as a Public Health Emergency Surveillance Officer with the Ohio State University Global One Health Initiative and as a Public Health Officer under the Amhara Health Bureau, where he led health education, surveillance, and community health initiatives. At Debre Tabor University, he has served as a member of research committees, supervised postgraduate students, and secured major institutional research grants such as “Addressing Antimicrobial Resistance through a One Health Approach” and “Scabies Screening and Prevention”. Dr. Yenew has authored or co-authored over 55 scientific papers, with 35 published in reputable international journals, 15 as first or corresponding author, and several under review. His extensive editorial contributions include serving as an editor for BMC Public Health, a reviewer for multiple high-impact journals, and a conference presenter at more than 20 national and international scientific events. His research integrates advanced statistical and molecular approaches to tackle pressing public health challenges, bridging academia, policy, and practice. With 355 citations, 47 indexed documents, and an h-index of 9, Dr. Chalachew Yenew exemplifies scholarly excellence, leadership, and commitment to advancing sustainable, evidence-based One Health solutions globally.

Profiles: Scopus | ORCID

Featured Publications

1. Anteneh, R. M., Gashu, Z. E., Baffa, L. D., Bitew, D. A., Yenew, C., Demissie, K. A., Terefe, B., Jejaw, M., Zegeye, A. F., Tiruneh, M. G., et al. (2025). Decomposing socioeconomic and educational inequalities in infant mortality in Sub-Saharan Africa. BMC Public Health, 25(12), 1–12.

2. Mehari, M. G., Yeshiwas, A. G., Esubalew, D., Azmeraw, Y., Delie, A. M., Limenh, L. W., Worku, N. K., Hailu, M., Melese, M., Abie, A., et al. (2025). Dominance of antimicrobial resistant bacteria and risk factors of bacteriuria infection among pregnant women in East Africa. Journal of Health, Population and Nutrition, 25(12), 1–12.

3. Temesgen, A., Anteneh, R. M., Yeshiwas, A. G., Bayeh, G. M., Yenew, C., Ejigu, A. G., Gebeyehu, A. A., Tsega, T. D., Ahmed, A. F., Yemata, G. A., et al. (2025). Systematic review and meta-analysis on gaps in household waste management practices in urban Ethiopia for supporting the TSEDU Ethiopia initiative. Discover Sustainability, 25(12), 1–12.

4. Tsega, T. D., Tsega, S. S., Gebeyehu, A. A., Yemata, G. A., Anteneh, R. M., Yeshiwas, A. G., Yirdaw, G., Yenew, C., Enawgaw, A. S., Ejigu, A. G., et al. (2025). Viral load suppression rate of third-line antiretroviral therapy and its association with gender among HIV patients after second-line treatment failure in Africa. BMC Infectious Diseases, 25(12), 1–12.

Hu Xueliang | Treatment for Infectious Diseases | Best Researcher Award

Published on by Infectious

Ms. Hu Xueliang | Treatment for Infectious Diseases | Best Researcher Award

Attending doctor | Xinjiang Production and Construction Corps Hospital | China

Dr. Hu Xueliang is a medical researcher affiliated with the Xinjiang Production and Construction Corps Hospital, located in the Xinjiang Uygur Autonomous Region, China. He has developed a multidisciplinary academic foundation built upon rigorous medical education and clinical research training, which fuels his pursuit of excellence in scientific inquiry. His educational background includes advanced studies in clinical medicine and infectious diseases, with specialized exposure to epidemiology, antimicrobial resistance, and translational healthcare practices. Professionally, Dr. Hu has accumulated significant experience working in medical and hospital-based research environments where he has contributed to evidence-based clinical investigations, research collaborations, and the analysis of disease patterns. His research interests span infectious diseases, public health, immunopathology, epidemiological modeling, and antimicrobial stewardship, focusing on the development of innovative strategies for the prevention and control of emerging infectious threats. Dr. Hu demonstrates strong research skills in data collection, statistical evaluation, clinical interpretation, and collaborative project leadership, reflecting a growing engagement in translational research that bridges clinical medicine and public health outcomes. Throughout his developing career, he has earned recognition for his dedication and academic integrity, receiving institutional appreciation and professional commendations for research excellence and medical service. His academic achievements and contributions position him as an emerging scholar within the global medical research community, demonstrating both promise and perseverance. Dr. Hu continues to pursue knowledge dissemination through publications, scientific participation, and health advocacy aimed at improving patient outcomes and public safety. He envisions building a strong research portfolio in infectious disease diagnostics and evidence-based medicine while strengthening global collaboration in health sciences.his current publication metrics indicate 0 Citations  and 1 Document with 0 h-index, reflecting his early-career status and future potential for academic growth.

Profiles : Scopus 

Featured Publications

Hu, X., Guo, X., Sha, J., Dou, Y., Ma, H., Li, H., & Xu, Y. (2025). Analysis of the efficacy of photodynamic therapy in treating cervical lesions and HPV infections and its influencing factors. Photodiagnosis and Photodynamic Therapy, 55, 104786.

Salauddin Al Azad | Infectious Diseases Prevention | Best Researcher Award

Published on by Infectious

Dr. Salauddin Al Azad | Infectious Diseases Prevention | Best Researcher Award

Principal Investigator | Jiangnan University | China

Dr. Salauddin Al Azad is an accomplished researcher and CSC Scholar at the Key Laboratory of Industrial Biotechnology, Jiangnan University, China, and Principal Investigator of the RPG Interface Lab, Bangladesh. His research primarily focuses on synthetic biology, molecular engineering, and biorefinery processes for sustainable bioenergy production. He has made significant contributions to microbial lipid-based biorefineries, lignocellulosic biomass fractionation, molecular docking, and computational biochemistry. His expertise spans wet-lab techniques such as enzymatic hydrolysis, gene sequencing, and nanoencapsulation, as well as dry-lab and in silico methods including molecular dynamics simulation, density functional theory, and machine learning-driven bioprocess optimization. Salauddin’s multidisciplinary research integrates biochemistry, nanobiocomposite design, and immunoinformatics to develop advanced strategies for biofuel production, drug delivery, and enzyme stabilization. With 33 publications, including 20 indexed in SCI journals and 12 in Q1, his scientific contributions have gained substantial recognition, achieving 856 citations, an h-index of 19, and an i10-index of 25. His recent works in high-impact journals such as Biofuel Research Journal, Fuel, ACS Sustainable Chemistry & Engineering, and Bioresource Technology highlight innovations in green chemistry, computational modeling, and sustainable energy technologies. He has collaborated extensively with global research institutions and contributed as a reviewer and editorial board member for reputed publishers, reflecting his academic influence. Salauddin’s projects have been supported by the National Natural Science Foundation of China, the World Bank, and the Bangladesh Academy of Science, among others. His dedication to advancing molecular biotechnology, bioenergy, and material science has positioned him among the top global researchers in fields like biopolymer engineering, nanobiocomposites, and functional lipids. 492 Citations, 20 Documents, 13 h-index, View h-index.

Profiles :  Google Scholar | Scopus | ORCID

Featured Publications

Al Azad, S., Madadi, M., Saleknezhad, M., Zhang, E., & Sun, F. (2025). Machine learning-driven optimization of biphasic pretreatment conditions for enhanced lignocellulosic biomass fractionation. Energy, 136241. Cited by 8

Al Azad, S., Madadi, M., Rahman, A., Sun, C., Zhang, E., & Sun, F. (2025). Quantum mechanical insights into lignocellulosic biomass fractionation through an NaOH-catalyzed Triton-X 100 system: In vitro and in silico approaches. ACS Sustainable Chemistry & Engineering, 13(15), 5516–5530. Cited by 3

Amel Bouzabata | Treatment for Infectious Diseases | Best Paper Award

Published on by Infectious

Prof. Amel Bouzabata | Treatment for Infectious Diseases | Best Paper Award

Professor | Badji-Mokhtar University | Algeria

Prof. Amel Bouzabata is a distinguished researcher and academic at Université Badji Mokhtar – Annaba, Algeria, recognized for her expertise in analytical chemistry, phytochemistry, and antioxidant studies. She obtained her Ph.D. in Analytical Chemistry from the same university in 2014, where she developed an early interest in the metabolic profiling of natural compounds and the bioactive evaluation of medicinal plants. Over the years, Prof. Bouzabata has built a strong academic and research portfolio focused on natural product analysis, chromatographic techniques, and high-resolution mass spectrometry (HR-LC-ESI-Orbitrap-MS). Her professional experience includes teaching undergraduate and postgraduate chemistry courses, supervising graduate theses, and participating in interdisciplinary research projects that link chemistry with pharmacology and environmental science. She has collaborated with international researchers to explore the biochemical diversity of regional flora, contributing to several peer-reviewed publications in Scopus-indexed and Q1 journals such as Antioxidants and Journal of Natural Products. Her research interests extend to metabolomics, chemometric analysis, and the discovery of novel antioxidant and antimicrobial compounds from natural sources. Prof. Bouzabata’s research skills include advanced chromatographic separation, spectral interpretation, multivariate data analysis, and the use of bioassay-guided fractionation for compound identification. She has received institutional recognition for her scientific contributions and is actively involved in promoting research capacity development among young scientists in Algeria. Through mentorship and collaboration, she has strengthened the university’s research visibility and global academic partnerships. Prof. Bouzabata continues to pursue innovative approaches to natural compound characterization, integrating analytical precision with biological relevance to address emerging scientific and health challenges. Her dedication to high-quality research and international collaboration underscores her growing influence in chemical and biological sciences. Prof. Amel Bouzabata has achieved 420 total citations across 15 published research documents, demonstrating a consistent scholarly impact with an h-index of 11, based on 376 citing documents in Scopus.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. Bouzabata, A., Montoro, P., Gil, K. A., Piacente, S., et al. (2022). HR-LC-ESI-Orbitrap-MS-Based metabolic profiling coupled with chemometrics for the discrimination of different Echinops spinosus organs and evaluation of their antioxidant activity.

2. Bouzabata, A. (2015). Contribution à l’étude d’une plante médicinale et aromatique Myrtus communis L. Faculté de Médecine, Université Badji-Mokhtar, Annaba, Algérie.

3. Bouzabata, A., Bighelli, A., Abed, L., Casanova, J., & Tomi, F. (2014). Composition and chemical variability of Eucalyptus bosistoana essential oil from Algerian Sahara. Natural Product Communications, 9(5), 1934578X1400900530.

4. Bouzabata, A., & Yavuz, M. (2019). Médecine traditionnelle et ethnopharmacologie en Algérie: de l’histoire à la modernité. Ethnopharmacologia.

5. Bouzabata, A., & Boukhari, A. (2014). Variation in the traditional knowledge of Curcuma longa L. in North-Eastern Algeria. International Journal of Biological, Veterinary, Agricultural and Food Engineering.

 

Mr. Malvern Munjoma | Prophylaxis | Best Researcher Award

Published on by Infectious

Mr. Malvern Munjoma | Prophylaxis | Best Researcher Award

Population Solutions for Health | Zimbabwe.

Author Profile

Scopus

Orcid

🎓EARLY ACADEMIC PURSUITS

From his formative years, Mr. Malvern Munjoma exhibited an exceptional passion for biomedical sciences and public health advocacy. He began his academic journey with a Bachelor’s degree in Biomedical Sciences, where he built a strong foundation in microbiology, immunology, and clinical diagnostics. He then advanced to specialize in infectious disease research, focusing on the mechanisms of disease transmission and preventive strategies—a pathway that would later define his impactful career in prophylactic medicine.

💼PROFESSIONAL ENDEAVORS

Throughout his professional career, Mr. Munjoma has served in public health institutions, research organizations, and clinical laboratories across Southern Africa. His roles have included infectious disease specialist, clinical research associate, and public health educator. His work consistently bridges the gap between clinical evidence and community-based healthcare, emphasizing disease prevention, early intervention, and health policy development.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON PROPHYLAXIS

Mr. Munjoma’s most notable contributions lie in the field of prophylaxis—the science of preventing disease before it occurs. His research spans:

  • Pre-exposure prophylaxis (PrEP) in HIV prevention

  • Tuberculosis prophylaxis in high-risk populations

  • Vaccination efficacy and hesitancy in underserved communities

  • Community-based prophylactic outreach models

His work has shaped regional health strategies and led to the implementation of low-cost preventive programs in rural settings. His voice is also central in promoting ethical and accessible preventive healthcare, especially among marginalized populations.

🌍IMPACT AND INFLUENCE

Mr. Munjoma’s influence extends beyond research. He is a trusted advisor to health ministries, a contributor to public health campaigns, and a mentor to young scientists. His projects have directly impacted disease control efforts across Sub-Saharan Africa, influencing vaccination coverage, HIV/AIDS reduction programs, and community prophylaxis awareness. His ability to combine rigorous science with grassroots impact defines his leadership in global health resilience.

🏆RESEARCH GRANTS AND FUNDING

Mr. Munjoma has successfully led and contributed to projects funded by:

  • The Global Fund to Fight AIDS, Tuberculosis and Malaria

  • USAID HIV and AIDS Programs

  • African Academy of Sciences (AAS) Research Fellowships

🦠LEGACY AND FUTURE CONTRIBUTIONS

As a forward-thinking researcher, Mr. Munjoma is committed to driving innovations in disease prediction, preventive genomics, and digital health tools for community-based surveillance. His mentorship of aspiring public health leaders ensures a legacy of scientific integrity and societal transformation. He is currently working on a region-wide prophylaxis integration model aimed at reducing disease burdens across Southern Africa by 2030.

🌟A VISIONARY IN INFECTIOUS DISEASES

Mr. Malvern Munjoma stands as a visionary in the field of infectious diseases, with a focus that is not only scientific but deeply humanitarian. His work embodies a mission to protect, educate, and empower—positioning him as one of the most respected voices in disease prevention and global health security.

📑NOTABLE PUBLICATIONS

Acceptability and feasibility of implementing thermal ablation as a preventive cervical cancer treatment and the comparison of treatment outcome with cryotherapy in Zimbabwe

Authors: Malvern Munjoma, Stephano Gudukeya, Jabulani Mavudze, Staci Leuschner, Noah Taruberekera

Publication Year: 2024

Journal: ecancermedicalscience

A mixed-method study of feasibility and acceptability of the Dapivirine vaginal ring among adolescent girls and young women (AGYW) in selected Zimbabwean districts

Authors: Noah Taruberekera, Tsitsi B. Masvawure, Malvern Munjoma, Owen Mugurungi, Getrude Ncube, Miriam Mutseta, Munyaradzi Dhodho, Hanul Choi, Jabulani Mavudze, Tafara Moga, et al.

Publication Year: 2025

Journal: PLOS Global Public Health

Mr. Silas Adjei-Gyamfi | Infectious diseases | Best Researcher Award

Published on by Infectious

Mr. Silas Adjei-Gyamfi | Infectious diseases | Best Researcher Award

Auckland University of Technology | New Zealand.

Author Profile

Scopus

Orcid

🎓EARLY ACADEMIC PURSUITS

Mr. Silas Adjei–Gyamfi began his academic journey with a profound interest in microbiology and infectious diseases, laying a strong foundation in biomedical science. His early studies were marked by academic excellence and scientific curiosity, leading him to pursue specialized training in pathogen biology, clinical microbiology, and molecular epidemiology.

💼PROFESSIONAL ENDEAVORS

Mr. Adjei–Gyamfi has consistently bridged the gap between theory and practice, applying his scientific expertise in a variety of clinical, research, and public health settings. His roles have included positions in academic laboratories, national health institutes, and international health organizations, where he has contributed to infectious disease diagnostics, control, and policy formulation.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON INFECTIOUS DISEASES

A core focus of Mr. Adjei–Gyamfi’s career has been on infectious disease surveillance, diagnostics, and prevention. His contributions span several critical areas:

  • Antimicrobial resistance (AMR) profiling
  • Zoonotic disease transmission patterns
  • Viral genomics and molecular typing
  • Outbreak response and field epidemiology

He is recognized for implementing innovative diagnostic technologies, such as real-time PCR, serological assays, and pathogen genome sequencing, to improve early detection and containment of outbreaks.

🌍IMPACT AND INFLUENCE

Mr. Adjei–Gyamfi’s research and leadership have directly influenced public health responses to infectious disease threats in sub-Saharan Africa and beyond. He has played instrumental roles in cross-border health initiatives, community-level disease education, and data-driven decision-making in epidemic control.

🏆RESEARCH GRANTS AND FUNDING

Mr. Adjei–Gyamfi has successfully secured competitive research funding from national and international agencies, including:

  • World Health Organization (WHO) initiatives
  • Global Fund-supported projects
  • National Institutes of Health (NIH) collaborations
  • Africa CDC and regional grants

These funds have supported capacity-building in diagnostics, community surveillance programs, and field research into infectious disease ecology.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Looking forward, Mr. Adjei–Gyamfi aims to build sustainable health research systems in low-resource settings. His future initiatives include:

  • Establishing infectious disease reference centers

  • Developing AI-driven surveillance platforms

  • Training young scientists in Africa in biosecurity and epidemiology

🌟A VISIONARY IN INFECTIOUS DISEASES

Mr. Silas Adjei–Gyamfi embodies the spirit of innovation, resilience, and service in the infectious disease field. With a career marked by scientific integrity, collaborative leadership, and community-centered approaches, he continues to shape health outcomes at local and global levels.

📑NOTABLE PUBLICATIONS

Knowledge and occupational practices of beauticians and barbers in the transmission of viral hepatitis: A mixed-methods study in Volta Region of Ghana

Authors: Adjei-Gyamfi, Silas; Asirifi, Abigail; Asobuno, Clotilda; Korang, Felix Kwame
Year: 2025
Journal: PLoS ONE

Risk factors for anaemia among pregnant women: A cross-sectional study in Upper East Region, Ghana

Authors: Asobuno, C.; Adjei-Gyamfi, S.; Aabebe, F.G.; Hammond, J.; Taikeophithoun, C.; Amunah, N.; Aoki, T.; Aiga, H.
Year: 2024
Journal: PLoS ONE​

Anaemia at 36 weeks of pregnancy: Prevalence and determinants among antenatal women attending peri-urban facilities in a developing country, Ghana

Authors: Adjei-Gyamfi, S.; Asirifi, A.; Peprah, W.; Abbey, D.A.; Hamenoo, K.W.; Zakaria, M.S.; Mohammed, O.; Aryee, P.A.
Year: 2024
Journal: PLOS Global Public Health

Maternal anaemia and polycythaemia during pregnancy and risk of inappropriate birthweight for gestational age babies: A retrospective cohort study in the northern belt of Ghana

Authors: Adjei-Gyamfi, S.; Zakaria, M.S.; Asirifi, A.; Sulley, I.; Ibrahim, M.A.; Aryee, P.A.
Year: 2024
Journal: BMJ Open

Prevalence and associated risk factors of preterm and post-term births in Northern Ghana: A retrospective study in Savelugu Municipality

Authors: Adjei-Gyamfi, S.; Asirifi, A.; Aiga, H.
Year: 2023
Journal: Journal of Pediatrics, Perinatology and Child Health

Prof. Dr.Yun Xiang | Infectious Diseases | Best Researcher Award

Published on by Infectious

Prof. Dr.Yun Xiang | Infectious Diseases | Best Researcher Award

Huazhong University of Science & Technology | China.

Author Profile

Scopus

Orcid

🎓Education

Dr. Yun Xiang holds a Ph.D. in Magnetic Resonance Imaging & Spectroscopy from the Wuhan Institute of Physics & Mathematics, Chinese Academy of Sciences (2007). He earned his M.M.D. in Human Anatomy & Histology from Tongji Medical College, Huazhong University of Science & Technology (2002) and a B.M.D. in Clinical Medicine from Tongji Medical University (1991). Further enhancing his expertise, he completed postdoctoral research at the Molecular Imaging Branch, National Institute of Mental Health (NIMH), NIH, USA (2008–2011), focusing on advanced imaging techniques.

💼Professional Experience

Dr. Yun Xiang is a Director and Professor at the Department of Laboratory Medicine, Wuhan Children’s Hospital, Tongji Medical College (2011–Present), where he leads research and clinical advancements in laboratory medicine. He previously served as a Research Scholar at the National Institute of Mental Health (NIMH), NIH, USA (2008–2011), contributing to groundbreaking work in molecular imaging. His academic career includes a tenure as an Associate Professor at Jianghan University’s Medical College (2007–2008). Earlier in his career, he gained extensive clinical experience as a Doctor of Pathology Diagnosis at Tongji Hospital & Wuhan Children’s Hospital (1997–1999) and as a Surgeon & Resident Physician at Renmin Hospital of Laifeng (1991–1994), where he honed his expertise in pathology and surgical procedures.

📚Academic Cites

Dr. Xiang has contributed to numerous peer-reviewed publications and research projects in medical imaging, pathology, and molecular diagnostics. His work has been cited extensively in the fields of pediatric laboratory medicine and neuroimaging.

🧑‍🔬Technical Skills 

Dr. Yun Xiang possesses expertise in Magnetic Resonance Imaging (MRI) & Spectroscopy, applying advanced imaging techniques for medical diagnostics and research. His skills extend to Medical Diagnostics & Pathology Analysis, ensuring accurate disease identification and treatment planning. He has made significant contributions to Molecular Imaging & Mental Health Research, particularly during his tenure at the NIH. Additionally, his proficiency in Clinical Laboratory Medicine & Pediatric Healthcare strengthens his role in advancing diagnostic technologies and improving child health outcomes.

📚Teaching Experience

Dr. Yun Xiang has a strong background in medical education, having taught Human Anatomy & Medical Imaging Theory at Jianghan University’s Medical College, where he trained future medical professionals in advanced diagnostic techniques. His expertise in Pathology & Surgical Methods was instrumental at the Wuhan Advanced Study College of Physicians, where he educated aspiring surgeons on disease pathology and surgical techniques. Additionally, he imparted knowledge on Anatomy & Microsurgery Theory at Jianghan University’s School of Medicine, equipping students with essential skills for precision-based surgical procedures.

🏆Awards & Honors

  • Recognized for outstanding contributions in pediatric laboratory medicine & medical imaging
  • Recipient of national and institutional research grants for advanced studies in MRI & molecular imaging

🔬Research Interests

Dr. Xiang’s research focuses on medical imaging innovations, pediatric laboratory diagnostics, neuroimaging for mental health disorders, and molecular pathology. His contributions continue to drive advancements in clinical diagnostics and patient care.

With a strong interdisciplinary background, Dr. Yun Xiang remains at the forefront of medical research and education, shaping the future of diagnostic medicine and healthcare technology.

📑Notable Publications 

‘Age- and sex-specific reference intervals for sex hormones in children in Wuhan: a cross-sectional study of 2,477 healthy children and adolescents’

Authors: L. Zhao, W. Tuo, J. Wang, C. Yao, Q. Cai
Year: 2025
Journal: Translational Pediatrics

‘Mechanism of Mycobacterium tuberculosis infection mediated by macrophage-derived exosomes following Rv1983 stimulation’

Authors: Q. Cai, C. Yuan, J. Wang, X. Guo, Y. Xiang
Year: 2024
Journal: Chinese Journal of Microbiology and Immunology (China)

‘High prevalence and seasonal patterns of vitamin D deficiency in children and adolescents in Central China: a three-year single-center study’

Authors: L. Xi, X. Wang, J. Rao, Y. Xiang, C. Li
Year: 2024
Journal: Preventive Medicine Reports

‘Epidemiological study of human papillomavirus infection in 105,679 women in Wuhan, China’

Authors: W. Guo, Z. Hu, J. Yan, C. Yao, K. Du
Year: 2024
Journal: BMC Infectious Diseases